In lung cancer, CAF-secreted lactate induces EMT through H3K18 lactylation at the METTL3 promoter, enhancing tumor progression and contributing to resistance against EGFR-TKIs through the CTHRC1-glycolysis-H3K18la feedback loop [109]. Here, METTL3 is linked to neoplasm.